LKT Labs

Biochemicals for Life Science Research

PJ34 Hydrochloride

Product ID P3600
Cas No. 344458-15-7
Purity ≥95%
Product Unit SizeCostQuantityStock
1 mg $83.40 In stock
5 mg $212.90 In stock
25 mg $648.30 In stock
Bulk Quote

Quicklinks

Description

PJ34 is a phenanthridinone derivative that acts as a competitive poly(ADP)-ribose polymerase (PARP) inhibitor. PJ34 exhibits cardioprotective, neuroprotective, anticancer, and anti-diabetic activities. In in vitro and in vivo models of oxygen glucose deprivation, PJ34 protects against stroke-related ischemic brain injury. This compound is also cardioprotective against myocardial infarction, decreasing infarct size and postsystolic shortening. In diabetic NOD mice, PJ34 decreased insulitis, beta-cell destruction, and diabetes incidence by decreasing islet IFN-γ expression and inducing apoptosis in islet-infiltrating leukocytes. In mouse models of allergic encephalitis, PJ34 exhibits protective benefit by shifting the immune response from a pro-inflammatory Th1-mediated response to an anti-inflammatory Th2-mediated response. Additionally, in a variety of cancer cell lines, PJ34 induces G2/M phase mitotic arrest and caspase-depedent apoptosis, potentially due to direct antagonism of Pim-1 kinase.

Product Info

Cas No.

344458-15-7
Purity

≥95%
Formula

C17H17N3O2 • HCl
Formula Wt.

331.80
IUPAC Name

2-(dimethylamino)-N-(6-oxo-5H-phenanthridin-2-yl)acetamide;hydrochloride
Solubility

DMSO 66 mg/mL (198.91 mM) Water 66 mg/mL (198.91 mM) Ethanol Insoluble
Appearance

Light grey to light brown

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

P3600 MSDS PDF
Info Sheet

P3600 Info Sheet PDF
Brochures

PARP Inhibitors Flyer

References

Antolín AA, Jalencas X, Yélamos J, et al. Identification of pim kinases as novel targets for PJ34 with confounding effects in PARP biology. ACS Chem Biol. 2012 Dec 21;7(12):1962-7. PMID: 23025350.

Gangopadhyay NN, Luketich JD, Opest A, et al. Inhibition of poly(ADP-ribose) polymerase (PARP) induces apoptosis in lung cancer cell lines. Cancer Invest. 2011 Nov;29(9):608-16. PMID: 22011283.

Madison DL, Stauffer D, Lundblad JR. The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest. DNA Repair (Amst). 2011 Oct 10;10(10):1003-13. PMID: 21840268.

Scott GS, Kean RB, Mikheeva T, et al. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation. J Pharmacol Exp Ther. 2004 Sep;310(3):1053-61. PMID: 15159442.

Suarez-Pinzon WL, Mabley JG, Power R, et al. Poly (ADP-ribose) polymerase inhibition prevents spontaneous and recurrent autoimmune diabetes in NOD mice by inducing apoptosis of islet-infiltrating leukocytes. Diabetes. 2003 Jul;52(7):1683-8. PMID: 12829633.

Faro R, Toyoda Y, McCully JD, et al. Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor. Ann Thorac Surg. 2002 Feb;73(2):575-81. PMID: 11845877.

Abdelkarim GE, Gertz K, Harms C, et al. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Int J Mol Med. 2001 Mar;7(3):255-60. PMID: 11179503.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.